Tracks Care and Outcomes in Minor Stroke With Large Vessel Blockage
Records treatment and follows adults with mild stroke and a large artery blockage.
Plain-language title generated from the registry record
Registry title: Therapy Evaluation in Patients With Minor Stroke and Large Vessel Occlusion
Key facts
- Where
- Hangzhou, ChinaSee the site
Where in China
- Sir Run Run Shaw HospitalHangzhou, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Sir Run Run Shaw Hospital
- Trial code
- NCT06633809
- Record updated
- 9 October 2024
- Original description
This multicenter registry study, which record the therapy strategy and follows up these acute ischemic stroke (AIS) patients with low NIHSS and large vessel occlusion (LVO), is intended to provide the important data for therapy evaluation and prognostic prediction of the LVO patients with low NIHSS.Read full original descriptionShow less
Therapy Evaluation in Patients With Minor Stroke and Large Vessel Occlusion: A Prospective Multicenter Registry Study
This multicenter registry study, which record the therapy strategy and follows up these acute ischemic stroke (AIS) patients with low NIHSS and large vessel occlusion (LVO), is intended to provide the important data for therapy evaluation and prognostic prediction of the LVO patients with low NIHSS.
Inclusion: Aged 18 years or older; Acute ischemic stroke patients of NIHSS 0-5 with 24 hours after onset; Proximal intracranial artery occlusion on NCCT/CTA or MRI/MRA showing occlusion of the intracranial ICA, M1, or proximal M2 vessel; Baseline ASPECTS ≥6 or infarct Core Volume of < 70 on NCCT/DWI/CTP; Pre-mRS≤1.
Exclusion: Participation in any investigational study in the previous 30 days; Any sign of intracranial hemorrhage on baseline CT/MR; Seizures at stroke onset; Baseline blood glucose of <2.78 mmol or >22.20 mmol, or platelet count < 100,000/uL or serum creatinine levels > 3.0 mg/dL.